The City of Chicago has announced its plans to proceed with the extension of the 606 trail in Bucktown. The extension will only be a portion of the greater planned expansion that will take the trail into the Lincoln Yards megadevelopment, near which we saw another two residential buildings proposed earlier this week. The Chicago Department of Transportation is leading the work with an unannounced design team already working on plans.
Initial details have been revealed for a mixed-use development at 1840 N Marcey Street in Lincoln Park. Located just west of N Clybourn Avenue and across the river from Lincoln Yards, the proposal will replace a one-story commercial building adding on to the recently announced 2033 N Kingsbury Avenue. Similar to that project, this one is also being developed by Sterling Bay with local firm SCB working on its design.
An updated construction timeline has been revealed for the Lincoln Yards mega development near Goose Island. With work completed on the initial phase of Ally at 1229 W Concord Place, developer Sterling Bay presented their updated phasing plan closer to what was revealed in 2021 during a recent community meeting. The next round of construction will also be phased out and with structures designed by various firms and plenty of new outdoor space.
The Lincoln Yards mega-development is set to enter its next phase as two of its riverfront parcels, D2 and D3, are scheduled to break ground next month. Following the completion of the life sciences ofice building at 1229 W Concord early this year, developer Sterling Bay has reevaluated the phasing plan for the Hartshorne Plunkard Architecture and Gensler-designed project, likely due to shifts in the economy. This adjustment prioritizes the development of mixed-use structures at the D2 and D3 parcels, located just north of 1229 W Concord.
This weekend, Chicago YIMBY had the opportunity to tour the nearly complete 1229 W Concord Place, the first building of the broader Lincoln Yards plan. Developed by Sterling Bay, the plan calls for a 53-acre urban revamp of a former North Branch industrial corridor. This first installation will offer 320,000 square feet of Class A medical research labs geared towards biotechnology and bioscience tenant companies.
